Pacific Biosciences of California, Inc. Deferred Revenue
Pacific Biosciences of California, Inc. (PACB) had Deferred Revenue of $10.36 million as of 2013-09-30, per its 10-Q filed 2013-11-12.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRevenueCurrent · last filed 2013-11-12
- 2013-09-30: Deferred Revenue, Current $10.36M.
- 2013-06-30: Deferred Revenue, Current $3.35M.
- 2013-03-31: Deferred Revenue, Current $2.96M.
- 2012-12-31: Deferred Revenue, Current $3.38M.
| Period end | Deferred Revenue, Current |
|---|---|
| 2013-09-30 | $10.36M 10-Q · filed 2013-11-12 |
| 2013-06-30 | $3.35M 10-Q · filed 2013-08-09 |
| 2013-03-31 | $2.96M 10-Q · filed 2013-05-10 |
| 2012-12-31 | $3.38M 10-Q · filed 2013-11-12 |
| 2012-09-30 | $3.56M 10-Q · filed 2012-11-01 |
| 2012-06-30 | $4.17M 10-Q · filed 2012-08-07 |
| 2012-03-31 | $3.92M 10-Q · filed 2012-05-07 |
| 2011-12-31 | $4.24M 10-K · filed 2013-03-15 |
| 2011-09-30 | $3.97M 10-Q · filed 2011-11-14 |
| 2011-06-30 | $2.38M 10-Q · filed 2011-08-12 |
| 2010-12-31 | $3.22M 10-K · filed 2012-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |